Blog

What is a global risk mitigation plan & how can you use it to ensure a successful drug launch?

A Global Risk Mitigation Plan (GRMP) is a critical step in drug development as it…

CertaraMay 4, 2023

Press Coverage

FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers

2023 guidance from FDA on dosages in oncology provides further context on expectations with Project…

CertaraMay 3, 2023

Blog

Innovating sales & marketing digital engagement for pharma and med tech

The regulatory environment for Pharma and Med Tech creates business challenges for digital engagement. Many…

CertaraApril 21, 2023

On-Demand Webinar

Transforming Trial Success: AI’s Role in Clinical Trial Meta-Analysis

Published research and literature-based content holds valuable insight that can inform clinical trial execution and…

CertaraApril 19, 2023

On-Demand Webinar

Antibody-drug Conjugates in the Clinic: Key Considerations & the Role of Modeling in Expediting Development

Antibody-Drug Conjugates (ADCs) can be an ideal drug treatment for cancer because they deliver a…

CertaraApril 17, 2023

Video

Milestone Achieved: Simcyp 100

CertaraApril 11, 2023

Blog

Considerations for pricing & formulary access for DRG-funded hospital drugs

In the United States, treatments or medical services that require the patient be admitted into…

CertaraApril 6, 2023

Press Coverage

Using Quantitative Systems Pharmacology Modelling to Accelerate Drug Development

Model informed drug development (in silico modelling) continues to be a game changer in accelerating…

CertaraMarch 29, 2023

Press Coverage

Model-Informed Drug Development (MIDD) – EMA’s Advancement

Modelling and simulation (M&S) plays a crucial role in drug development. It allows information from…

CertaraMarch 29, 2023

White Paper

Advancing Biopharmaceutics & Drug Formulation Using In Silico Modeling

Model-Informed Formulation Development (MIFD) Increases Speed and Certainty for New and Generic Drugs

CertaraMarch 22, 2023

pre-update

What is a global risk mitigation plan & how can you use it to ensure a successful drug launch?

FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers

Innovating sales & marketing digital engagement for pharma and med tech

Transforming Trial Success: AI’s Role in Clinical Trial Meta-Analysis

Antibody-drug Conjugates in the Clinic: Key Considerations & the Role of Modeling in Expediting Development

Milestone Achieved: Simcyp 100

Considerations for pricing & formulary access for DRG-funded hospital drugs

Using Quantitative Systems Pharmacology Modelling to Accelerate Drug Development

Model-Informed Drug Development (MIDD) – EMA’s Advancement

Advancing Biopharmaceutics & Drug Formulation Using In Silico Modeling

Newsletter sign up

Quick links

Solutions

Contact